Product Information Protein full name T-cell leukemia/lymphoma protein 1A (Oncogene TCL-1) (Oncogene TCL1) (Protein p14 TCL1) Gene Id 8115 Immunogen Synthesized peptide derived from human TCL1 Uniprot ID P56279 Source Mouse/IgG2b, Kappa Concentration 1 mg/ml Purity The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. Applications IHC/IF Human 1: 200-1: 500 appendix Background TCL1A, also named as TCL1 and p14 TCL1, enhances cell proliferation, stabilizes mitochondrial membrane potential and promotes cell survival. TCL1A immunodetection is an independent marker of adverse outcome that could be used in routine settings for the management of DLCL patients. TCL1A expression is correlated with shorter time to treatment in chronic lymphocytic leukemia cases and shorter lymphoma-specific survival in mantle cell lymphoma series. It is a potential therapeutic target. Images Immunohistochemistry analysis of paraffin embedded human appendix using TCL1 (GB14151) at dilution of 1: 200 Storage Storage Store at -20 ℃ for one year. Avoid repeated freeze/thaw cycles. Storage Buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. NOTE: 1.This product is intended for research only. 2.This product is recommended to dilute with the Primary Antibody Dilution Buffer （ G2025 ）.